Clinical Scorecard: The Role of Neuroticism and Thyroid Hormones in Linking Anxiety and Depression to Non-Suicidal Self-Injury in Adolescents

At a Glance

Key Highlights

• Neuroticism fully mediates the association between anxiety and NSSI.
• TT3 and FT3 positively moderate the depression-NSSI relationship.
• TSH negatively moderates the depression-NSSI relationship, particularly in high-neuroticism individuals.
• NSSI prevalence is estimated at 17-18% in the general adolescent population.
• The study emphasizes the integration of psychological and neuroendocrine mechanisms in understanding NSSI.

Guideline-Based Recommendations

Diagnosis

• Assess depressive and anxiety symptoms using standardized scales (e.g., HAMD, HAMA).
• Evaluate personality traits, particularly neuroticism, using the Eysenck Personality Questionnaire.

Management

• Consider psychological interventions targeting neuroticism and emotional regulation.
• Monitor thyroid hormone levels in adolescents exhibiting NSSI behaviors.

Monitoring & Follow-up

• Regularly assess NSSI severity and emotional symptoms over time.
• Evaluate changes in thyroid hormone levels in relation to mood symptoms.

Risks

• High neuroticism is associated with increased risk of NSSI.
• Depressive and anxious moods are predictive of NSSI behaviors.

Patient & Prescribing Data

Adolescents aged 12–22 years with NSSI behaviors.

Thyroid hormone levels may influence treatment approaches for adolescents with NSSI.

Clinical Best Practices

• Incorporate assessments of neuroticism in evaluating adolescents at risk for NSSI.
• Utilize a multidisciplinary approach involving psychological and endocrinological assessments.

Related Resources & Content

• Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
• Eysenck Personality Questionnaire